These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 9585535

  • 1. Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3).
    Ugwu F, Van Hoef B, Bini A, Collen D, Lijnen HR.
    Biochemistry; 1998 May 19; 37(20):7231-6. PubMed ID: 9585535
    [Abstract] [Full Text] [Related]

  • 2. Modulation of cell-associated plasminogen activation by stromelysin-1 (MMP-3).
    Ugwu F, Lemmens G, Collen D, Lijnen HR.
    Thromb Haemost; 1999 Sep 19; 82(3):1127-31. PubMed ID: 10494776
    [Abstract] [Full Text] [Related]

  • 3. Native and non-glycosylated recombinant single-chain urokinase-type plasminogen activator are recognized by different receptor systems on rat parenchymal liver cells.
    van der Kaaden ME, Rijken DC, Groeneveld E, van Berkel TJ, Kuiper J.
    Thromb Haemost; 1995 Aug 19; 74(2):722-9. PubMed ID: 8585013
    [Abstract] [Full Text] [Related]

  • 4. Characterization of domain deletion and/or duplication mutants of a recombinant chimera of tissue-type plasminogen activator and urokinase-type plasminogen activator (rt-PA/u-PA).
    Nelles L, Lijnen HR, Van Nuffelen A, Demarsin E, Collen D.
    Thromb Haemost; 1990 Aug 13; 64(1):53-60. PubMed ID: 2148847
    [Abstract] [Full Text] [Related]

  • 5. Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3).
    Lijnen HR, Ugwu F, Bini A, Collen D.
    Biochemistry; 1998 Apr 07; 37(14):4699-702. PubMed ID: 9548733
    [Abstract] [Full Text] [Related]

  • 6. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.
    Colucci M, Cavallo LG, Agnelli G, Mele A, Bürgi R, Heim J, Semeraro N.
    Thromb Haemost; 1993 May 03; 69(5):466-72. PubMed ID: 8391727
    [Abstract] [Full Text] [Related]

  • 7. Nerve growth factor-gamma activates soluble and receptor-bound single chain urokinase-type plasminogen activator.
    Wolf BB, Vasudevan J, Henkin J, Gonias SL.
    J Biol Chem; 1993 Aug 05; 268(22):16327-31. PubMed ID: 8393859
    [Abstract] [Full Text] [Related]

  • 8. Binding of human single chain urokinase to Chinese Hamster Ovary cells and cloning of hamster u-PAR.
    Fowler B, Mackman N, Parmer RJ, Miles LA.
    Thromb Haemost; 1998 Jul 05; 80(1):148-54. PubMed ID: 9684801
    [Abstract] [Full Text] [Related]

  • 9. Thrombolytic and pharmacokinetic properties of a recombinant chimeric plasminogen activator consisting of a fibrin fragment D-dimer specific humanized monoclonal antibody and a truncated single-chain urokinase.
    Dewerchin M, Vandamme AM, Holvoet P, De Cock F, Lemmens G, Lijnen HR, Stassen JM, Collen D.
    Thromb Haemost; 1992 Aug 03; 68(2):170-9. PubMed ID: 1412163
    [Abstract] [Full Text] [Related]

  • 10. Activation with plasmin of tow-chain urokinase-type plasminogen activator derived from single-chain urokinase-type plasminogen activator by treatment with thrombin.
    Lijnen HR, Van Hoef B, Collen D.
    Eur J Biochem; 1987 Dec 01; 169(2):359-64. PubMed ID: 2961562
    [Abstract] [Full Text] [Related]

  • 11. Characterization of a recombinant chimeric plasminogen activator composed of a fibrin fragment-D-dimer-specific humanized monoclonal antibody and a truncated single-chain urokinase.
    Vandamme AM, Dewerchin M, Lijnen HR, Bernar H, Bulens F, Nelles L, Collen D.
    Eur J Biochem; 1992 Apr 01; 205(1):139-46. PubMed ID: 1313361
    [Abstract] [Full Text] [Related]

  • 12. The differential glycosylation of human pro-urokinase from various recombinant mammalian cell lines does not affect activity and binding to PAI-1.
    Sarubbi E, Nolli ML, Robbiati F, Soffientini A, Parenti F, Cassani G.
    Thromb Haemost; 1989 Nov 24; 62(3):927-33. PubMed ID: 2512681
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the in vitro fibrinolytic activities of low and high molecular weight single-chain urokinase-type plasminogen activator.
    de Munk GA, Groeneveld E, Rijken DC.
    Thromb Haemost; 1993 Sep 01; 70(3):481-5. PubMed ID: 8259553
    [Abstract] [Full Text] [Related]

  • 14. Differential detection of single-chain and two-chain urokinase-type plasminogen activator by a new immunoadsorbent-amidolytic assay (IAA).
    Corti A, Nolli ML, Cassani G.
    Thromb Haemost; 1986 Dec 15; 56(3):407-10. PubMed ID: 3105110
    [Abstract] [Full Text] [Related]

  • 15. An enzyme-linked immunosorbent assay for urokinase-type plasminogen activator (u-PA) and mutants and chimeras containing the serine protease domain of u-PA.
    Declerck PJ, Van Keer L, Verstreken M, Collen D.
    Thromb Haemost; 1992 Jan 23; 67(1):95-100. PubMed ID: 1377417
    [Abstract] [Full Text] [Related]

  • 16. Effect of fibrin-targeting on clot lysis with urokinase-type plasminogen activator.
    Lijnen HR, Dewerchin M, De Cock F, Collen D.
    Thromb Res; 1990 Feb 01; 57(3):333-42. PubMed ID: 2107593
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Characterization of a fusion protein consisting of amino acids 1 to 263 of tissue-type plasminogen activator and amino acids 144 to 411 of urokinase-type plasminogen activator.
    Nelles L, Lijnen HR, Collen D, Holmes WE.
    J Biol Chem; 1987 Aug 05; 262(22):10855-62. PubMed ID: 2956260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.